Optimal Dose of Ciprofol for Anesthesia Induction in Older Hypertensive Patients with Elevated Baseline Systolic Blood Pressure: A Bayesian Phase 1/2 Trial.
Fang Jiajia J, Gao Yang Y, Wang Yi Y, Wang Jiang J et al.
To identify the optimal ciprofol induction dose for older hypertensive patients with elevated baseline invasive systolic blood pressure (SBP ≥ 140 mmHg) using a Bayesian adaptive design. This single-center, seamless phase 1/2 trial enrolled 51 hypertensive patients aged 65-80 years with baseline invasive SBP ≥ 140 mmHg undergoing elective non-cardiac procedures. General anesthesia was induced with ciprofol (0.20-0.40 mg/kg), sufentanil (0.4 µg/kg), and rocuronium (1.0 mg/kg). Phase 1 used the Bayesian Optimal Interval (BOIN) design to determine the maximum tolerated dose (MTD). Dose-limiting toxicity (DLT) was defined as post-induction hypotension (PIH; mean arterial pressure [MAP] < 65 mmHg from induction to 3 minutes post-intubation). The target DLT probability was set at 45% to accommodate the high baseline hypotension risk in this cohort. Phase 2 adopted the Bayesian Optimal Phase 2 (BOP2) design to find the optimal biological dose (OBD), evaluating both efficacy (loss of consciousness within 2 minutes without rescue dosing) and safety. Phase 1 (n = 30) identified the MTD at 0.35 mg/kg (posterior mean PIH incidence: 33%, 95% credible interval [CrI]: 11%-61%). Phase 2 (n = 21) selected 0.25 mg/kg (n = 12) as the OBD, achieving a high induction success rate (91%, 95% CrI: 71%-99%) alongside a lower PIH risk (25%, 95% CrI: 6%-52%). The peak MAP after endotracheal intubation was higher with 0.25 mg/kg than 0.35 mg/kg (126.1 ± 20.9 vs 97.8 ± 14.8 mmHg; Bonferroni-adjusted P = 0.002). Guided by the Bayesian algorithm, 0.25 mg/kg was identified as the protocol-selected OBD for older hypertensive patients with baseline invasive SBP ≥ 140 mmHg, balancing reliable anesthesia with acceptable hypotension risks. However, compared with 0.35 mg/kg, this lower dose less effectively blunts intubation-induced hypertensive surges and requires careful hemodynamic monitoring.